Ефигало

Fingolimod is an oral medication used to treat relapsing forms of multiple sclerosis. It helps reduce flare-ups and slow disease progression. This EU-manufactured generic is taken once daily for immune system modulation. Suitable for adults with active MS.

Fingolimod is prescribed to manage relapsing forms of multiple sclerosis in adults. It is used to reduce the frequency of relapses and delay physical disability progression. The medication works by modulating the immune system to limit inflammation in the central nervous system. Patients often ask, 'what is Fingolimod used for' to understand its role in MS treatment.

Fingolimod helps stabilize neurological function by reducing immune system activity. Users may experience fewer MS symptoms over time, such as improved mobility or reduced fatigue. Some report better daily functioning due to fewer relapses. The effects develop gradually with consistent daily use.

Fingolimod requires careful monitoring, especially during the first dose, due to potential heart rate effects. Patients with certain heart conditions should discuss risks with their healthcare provider. Regular blood tests are recommended to check for liver function changes. Avoid sudden treatment stops without medical guidance.

Fingolimod may interact with medications that affect heart rhythm or the immune system, including some antidepressants and antiarrhythmics. Combining it with live vaccines is not advised due to reduced immune response. Strong CYP450 inhibitors can increase Fingolimod levels; consult a doctor before starting new drugs.